Literature DB >> 2877426

Effects of benzodiazepines on acquisition and performance: a critical assessment.

S O Cole.   

Abstract

Evidence related to the effects of benzodiazepines on learning and memory is reviewed in the contexts of human verbal learning studies and animal studies using both aversive and non-aversive paradigms. While the impairment of acquisition by benzodiazepines appears to be a robust phenomenon generalizing across species and experimental conditions, the impairment in the performance of an already-learned task by such drugs appears to be more restrictive and highly dependent upon experimental contingencies. Thus far, performance impairment appears to be found mainly in animal studies using non-aversive, food-motivated tasks, with such tasks being particularly well suited for investigating such a phenomenon. At present, there is a noticeable lack of knowledge regarding the neurochemical substrates underlying BDZ-induced impairment. Finally, some issues that may contribute to the presence or absence of a BDZ-induced performance impairment in published studies are briefly considered.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2877426     DOI: 10.1016/0149-7634(86)90013-8

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  13 in total

1.  Dissociation between the effects of benzodiazepine receptor agonists on behavioral vigilance and responsitivity.

Authors:  P Dudchenko; B Paul; M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Effects of ritanserin and chlordiazepoxide on sleep-wakefulness alterations in rats following chronic cocaine treatment.

Authors:  C Dugovic; T F Meert; D Ashton; G H Clincke
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Decreasing the Expression of GABAA α5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal Defects in the Ts65Dn Model of Down Syndrome.

Authors:  Verónica Vidal; Susana García-Cerro; Paula Martínez; Andrea Corrales; Sara Lantigua; Rebeca Vidal; Noemí Rueda; Laurence Ozmen; Maria-Clemencia Hernández; Carmen Martínez-Cué
Journal:  Mol Neurobiol       Date:  2017-07-17       Impact factor: 5.590

4.  Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.

Authors:  Miroslav M Savić; Dragan I Obradović; Nenad D Ugresić; James M Cook; P V V S Sarma; Dubravko R Bokonjić
Journal:  Psychopharmacology (Berl)       Date:  2005-02-18       Impact factor: 4.530

5.  Behavioral analysis of diazepam-induced memory deficits: evidence for sedation-like effects.

Authors:  L E Kalynchuk; C H Beck
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Buspirone impairment of performance of passive avoidance and spatial learning tasks in the rat.

Authors:  M J Rowan; W K Cullen; B Moulton
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

7.  Nitrous oxide induces an anxiolytic-like effect in the conditioned defensive burying paradigm, which can be reversed with a benzodiazepine receptor blocker.

Authors:  D A Czech; R M Quock
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Dose-dependent reversal of chlordiazepoxide-induced discrimination impairment by Ro 15-1788.

Authors:  S O Cole
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

9.  BetaCCM but not physostigmine enhancement of memory retrieval depends on emotional processes in mice.

Authors:  Daniel Beracochea; Aurelie Celerier; Christophe Pierard
Journal:  Psychopharmacology (Berl)       Date:  2004-04-03       Impact factor: 4.530

10.  Pharmacological dissociation between the spatial learning deficits produced by morphine and diazepam.

Authors:  R K McNamara; R W Skelton
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.